Urinary retention resident survival guide: Difference between revisions
Line 106: | Line 106: | ||
{{familytree | | | | | | | | | | | | | | | | |!| | | | }} | {{familytree | | | | | | | | | | | | | | | | |!| | | | }} | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | {{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | | | | | A10 | | | | | A10= <div style="float: left; text-align: left; width: 15em; padding:1em;">'''Evaluation''' <br> | ||
❑ [[collect urine sample by placing folley's catheter|<span style="color:white;">collect urine sample by placing folley's catheter</span>]] <br> | ❑ [[collect urine sample by placing folley's catheter|<span style="color:white;">collect urine sample by placing folley's catheter</span>]] <br> | ||
❑ [[Perform bladder ultrasound/rectal examination|<span style="color:white;">perform bladder ultrasound</span>]] | ❑ [[Perform bladder ultrasound/rectal examination|<span style="color:white;">perform bladder ultrasound</span>]] | ||
Line 120: | Line 120: | ||
❑ [[if neurological symptoms-CT head, MRI spine|<span style="color:white;">if neurological symptoms-CT head, MRI spine</span>]] <br> | ❑ [[if neurological symptoms-CT head, MRI spine|<span style="color:white;">if neurological symptoms-CT head, MRI spine</span>]] <br> | ||
</div>}} | </div>}} | ||
{{familytree | | | | | | | |!| | }} | {{familytree | | | | | | | | |!| | }} | ||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | | | | H01 | | | | | | | | | H01=<div style=" background: #FA8072; text-align: left; width: 20em"> {{fontcolor|#F8F8FF| Volume of urine in first 10-15 minutes of catheterization or with bladder ultrasound?}}</div> }} | {{familytree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | | | | | H01 | | | | | | | | | H01=<div style=" background: #FA8072; text-align: left; width: 20em"> {{fontcolor|#F8F8FF| Volume of urine in first 10-15 minutes of catheterization or with bladder ultrasound?}}</div> }} | ||
{{familytree | | | | | |,|-|^|-|.|}} | {{familytree | | | | | |,|-|^|-|.|}} | ||
{{familytree |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | I01 | | I02 | | I01= <div style=" background: #FA8072; text-align: center; width:20em"> {{fontcolor|#F8F8FF|'''>300ml'''}} </div> | I02=<div style="padding: 5px; background: #FFFFFF; text-align: center;">'''<200 ml'''</div>}} | {{familytree |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | | I01 | | I02 | | I01= <div style=" background: #FA8072; text-align: center; width:20em"> {{fontcolor|#F8F8FF|'''>300ml'''}} </div> | I02=<div style="padding: 5px; background: #FFFFFF; text-align: center;">'''<200 ml'''</div>}} | ||
{{familytree | | | | | |!| | | |!| | | }} | {{familytree | | | | | |!| | | |!| | | }} | ||
{{familytree |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | J01 | | J02 | | J01= <div style=" background: #FA8072; text-align: left; width:20em; padding:1em"> {{fontcolor|#F8F8FF|❑ suggest urinary retention-keep catheter in place if >400 ml|<span style="color:white;">>400 ml</span>]]}} </div> | J02= <div style="padding: 5px; background: #FFFFFF; text-align: center;">'''Urinary retention unlikely''' </div> }} | {{familytree |boxstyle= padding: 0; background: #FA8072; text-align: center;| | | | | J01 | | J02 | | J01= <div style=" background: #FA8072; text-align: left; width:20em; padding:1em"> {{fontcolor|#F8F8FF|❑ suggest urinary retention-keep catheter in place if >400 ml|<span style="color:white;">>400 ml</span>]]}} </div> | J02= <div style="padding: 5px; background: #FFFFFF; text-align: center;">'''Urinary retention unlikely''' </div> }} |
Revision as of 20:10, 27 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Synonyms and keywords:
Overview
Urinary retention can be defined as an inability to pass urine or incomplete emptying of the bladder. It is one of the most common presenting complaint encountered in the emergency department which can be acute or chronic. It is commonly seen in males as compared to females due to benign prostate hyperplasia. If undiagnosed or left untreated, this condition can be life threatening as it may lead to kidney damage and severe urosepsis. Acute urinary retention can be extremely uncomfortable, brings the patient immediately in attention and is initially managed by urethral or suprapubic catheterization. Chronic urinary retention is often asymptomatic, not easily identified and is linked to increased post void residual volume. A complete detailed history about current prescription, over the counter and herbal medications is necessary along with focused physical examination that must include neurological evaluation.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
CAUSES
Urinary retention in women
Urinary Retention is overall very rare in women and can be acute or chronic. Common causes include:
- Nerve injury during surgery-For example Episiotomy
- Medications-Atropine, Glycopyrrolate, Bupivacaine
- Obstructive causes-Vaginal hematoma, Vaginal packing, Sling, Foreign body, Pelvic organ prolapse, Urethral injury [1]
Urinary Retention in Men
Urinary retention is much more common in males with male to female ratio being 13:1.[2]
❑ Obstructive causes
- ❑ Benign Prostate Hyperplasia
- ❑ Prostate or Bladder Carcinoma
- ❑ Constipation
- ❑ Urolithiasis
- ❑ Urethral Stricture
- ❑ Phimosis or Paraphimosis
❑ Infectious Causes
- ❑ Prostatitis-
- ❑ Urethritis-
- ❑ Genital herpes
❑ Neurological Causes
- ❑ stroke
- ❑ spinal cord injury
- ❑ Demyelinating disorders-Guillain barre syndrome, diabetic neuropathy, Multiple sclerosis.
❑ Detrusor Muscle Dysfunction
❑ Medications
- ❑ Sympathomimetic alpha adrenergic agents-Phenylephrine
- ❑ Sympathomimetic beta adrenergic agents-Isoproterenol
- ❑ Antidepressants-Amitriptyline,Imipramine
- ❑ Antiarrhythmics-Quinidine, procainamide, Disopyramide
- ❑ Anticholinergics-Atropine, oxybutynin, glycopyrrolate
- ❑ Antiparkinsonian agents-Amantadine, trihexyphenidyl,levadopa, bromocriptine
- ❑ Antipsychotics-Haloperidol, fluphenazine
- ❑ Hormonal agents-estrogen, progesterone, testosterone
- ❑ Antihistamines-diphenhydramine, hydroxysine
- ❑ Antihypertensives-Hydralazine,nifedipine
- ❑ Others-indomethacin, morphine, dopamine,amphetamines
Diagnosis
A detailed history and a thorough physical examination may help in diagnosing the cause behind urinary retention.[2] [1] [3]
Volume of urine in first 10-15 minutes of catheterization or with bladder ultrasound? | |||||||||||||||||||||||||||||||||||
>300ml | <200 ml | ||||||||||||||||||||||||||||||||||
❑ suggest urinary retention-keep catheter in place if >400 ml | Urinary retention unlikely | ||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of [[disease name]] according the the [...] guidelines.
Do's
- The content in this section is in bullet points.
Don'ts
- The content in this section is in bullet points.
References
- ↑ "StatPearls". 2020. PMID 30860732.
- ↑ Serlin DC, Heidelbaugh JJ, Stoffel JT (2018). "Urinary Retention in Adults: Evaluation and Initial Management". Am Fam Physician. 98 (8): 496–503. PMID 30277739.
- ↑ Lepor H (2005). "Managing and preventing acute urinary retention". Rev Urol. 7 Suppl 8: S26–33. PMC 1477632. PMID 16985887.
- ↑ Roehrborn CG (2005). "Acute urinary retention: risks and management". Rev Urol. 7 Suppl 4: S31–41. PMC 1477606. PMID 16986053.
- ↑ Mevcha A, Drake MJ (2010). "Etiology and management of urinary retention in women". Indian J Urol. 26 (2): 230–5. doi:10.4103/0970-1591.65396. PMC 2938548. PMID 20877602.
- ↑ Hernández Hernández D, Tesouro RB, Castro-Diaz D (2013). "Urinary retention". Urologia. 80 (4): 257–64. doi:10.5301/RU.2013.11688. PMID 24419919.